← Back to All Filings

Colgate-Palmolive Officer Files Form 144 to Sell $2.32M in Common Stock

Medium SignificanceNovember 4, 2026 at 5:18:37 PM EST

COLGATE PALMOLIVE CO

$CL144CIK: 0000021665

Subscribe to track CL

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Colgate-Palmolive Co ($CL) – Form 144 Proposed Sale Insider: Hazlin John (Officer) Proposed Sale Amount: 23,376 shares (~$2,317,683.03) Date: November 4, 2026 Broker: Merrill Lynch Nature: Exercise of employee stock options (Broker-assisted cashless exercise)

Comprehensive Analysis

Overview

On November 4, 2026, John Hazlin, an Officer at Colgate-Palmolive Co ($CL), filed a Form 144 notice disclosing the intended sale of 23,376 shares of common stock with an estimated aggregate market value of $2,317,683.03 (approximately $99.15 per share).

Transaction Details

  • Filer: Hazlin John
  • Position: Officer
  • Security: Common Stock
  • Shares to Sell: 23,376
  • Aggregate Market Value: $2,317,683.03
  • Acquisition Origin: Acquired on November 4, 2026, via an exercise of employee stock options funded through a broker-assisted cashless exercise.
  • Broker: Merrill Lynch
  • Approximate Sale Date: November 4, 2026
  • Issuer Outstanding Shares: 794,920,513

Significance & Market Impact

The planned disposition represents approximately 0.003% of the company's 794.9M outstanding shares, presenting minimal market dilution or direct liquidity pressure. Because the transaction originates from a broker-assisted cashless exercise of stock options, it represents routine executive compensation realization rather than an unexpected open-market divestment of core holdings.

Topics:#ColgatePalmolive#CL#Form144#InsiderTrading#StockOptions

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.